A recent study suggests that people who come off popular weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who end conventional lifestyle regimens.
Published data in a major medical journal shows that while overweight individuals frequently drop substantial amounts of their body weight while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"People using these treatments should be cognizant of the danger of fast rebound weight gain when the therapy is stopped," warns researcher Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment weight within about a year and a half.
Comparing Treatments
The analysis, which examined 37 of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with other pills.
The team emphasize that individuals who shed pounds through diet and exercise generally experience a more gradual creep back—perhaps 0.1 kg a month—post-intervention.
The Reason for the Rapid Regain
Nutrition scientists believe the mechanism of the jabs is key to understanding the amplified rebound.
GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing the hormone levels several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' leads to hunger is unsuppressed, making binge eating a significant risk."
A Chronic Condition?
Medical guidelines advise the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, given the high risk of relapse, the therapy should be considered life-long.
This opinion is reinforced by drug manufacturers, who note that the findings "highlight the persistent nature of excess weight," comparing it to managing conditions like high blood pressure.
User Accounts
Individuals who have come off the jabs report a powerful return of hunger.
"It was like something flipping and you become starving," recalled a patient.
This difficulty is worsened if individuals have not adopted sustainable lifestyle or habit modifications during treatment.
Widespread Interest
Figures show that millions of people in the UK have used these injections in the past year, with desire being substantial.
- Adoption is more common among women than males.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the drugs through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while these medications are effective tools for weight loss, they are not a permanent solution and lasting health benefits hinges on combined lifestyle changes.
